Modern Strategy for Preclinical Pharmaceutical R&D by David Cavalla

  •
1 1

Modern Strategy for Preclinical Pharmaceutical R&D by David Cavalla

Checking stock...
Checking stock...
Summary

The emphasis on cost-effectiveness within the pharmaceutical industry has caused it to outsource some development work. This text addresses the advantages and disadvantages of collaborations between industrial research and development divisions and contract research organizations and universities.

The feel-good place to buy books
  • Free delivery in Ireland
  • Supporting authors with AuthorSHARE
  • 100% recyclable packaging
  • Proud to be a B Corp – A Business for good
  • Buy-back with Ziffit

Modern Strategy for Preclinical Pharmaceutical R&D by David Cavalla

The emphasis on cost-effectiveness within the pharmaceutical industry has caused it to outsource some development work. This text addresses the advantages and disadvantages of collaborations between industrial research and development divisions and contract research organizations and universities.

You might also like

David Cavalla is an expert on secondary uses for existing drugs, or drug repurposing. He currrently operates through his consultancy, Numedicus Ltd, having worked in drug repurposing for 15 years. Previously he was CEO of Arachnova, and prior to that held various senior positions in pharmaceutical drug discovery at GSK and Napp Research Centre. He has written widely on drug discovery strategy, and is the author of 70 published papers and patents.

SKU Unavailable
ISBN 13 9780471971177
ISBN 10 0471971170
Title Modern Strategy for Preclinical Pharmaceutical R&D
Author David Cavalla
Condition Unavailable
Binding Type Hardback
Publisher John Wiley & Sons Inc
Year published 1997-03-21
Number of pages 228
Cover note Book picture is for illustrative purposes only, actual binding, cover or edition may vary.